Trials / Completed
CompletedNCT02961556
General Clinical Study of AJG555 in Pediatric Patients With Chronic Constipation
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 39 (actual)
- Sponsor
- EA Pharma Co., Ltd. · Industry
- Sex
- All
- Age
- 2 Years – 14 Years
- Healthy volunteers
- Not accepted
Summary
This baseline-controlled, open-label, multicenter study evaluates the efficacy and safety of AJG555 orally administered for 2 weeks in pediatric participants with chronic constipation. The safety and efficacy of 12 weeks of administration will also be evaluated.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | AJG555 | Participants will receive 1 to 6 sachets daily per participants' age and conditions. |
Timeline
- Start date
- 2016-11-15
- Primary completion
- 2017-06-09
- Completion
- 2017-08-04
- First posted
- 2016-11-11
- Last updated
- 2017-10-24
Locations
11 sites across 1 country: Japan
Source: ClinicalTrials.gov record NCT02961556. Inclusion in this directory is not an endorsement.